Join to View Full Profile
9500 Euclid AveR35Cleveland, OH 44195
Phone+1 216-313-3420
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Heng, MD is an oncologist in Cleveland, Ohio. He is currently licensed to practice medicine in Ohio. He is a Leader at University of Calgary.
Education & Training
University of Calgary Faculty of MedicineClass of 2002
Certifications & Licensure
OH State Medical License 2007 - 2026
Publications & Presentations
PubMed
- Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?Mustafa Soytas, Alice Dragomir, Ghady Bou-Nehme Sawaya, Charles Hesswani, Maude Tanguay
BJU International. 2025-05-01 - Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer-Specific Mortality, and All-Cause Mortality.Anita Robert, Ranjeeta Mallick, Daniel I McIsaac, Luke T Lavallée, Bimal Bhindi
The Journal of Urology. 2025-04-01 - Treatment of Metastatic Renal Cell Carcinoma: Lack of Consensus Urges the Need for a Well-organized Multidisciplinary Team.Stijn Muselaers, Daniel Heng, Chiara Ciccarese, Shankar Siva
European Urology Oncology. 2025-03-15
Press Mentions
Survival in mRCC Varies by Histologic Subtype, Metastasis SiteJanuary 28th, 2021
Kidney Cancer UK Presents Survey at IKCC2018April 23rd, 2018
